Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
CMV pp65 (25–305)
AviHis加载中…
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg
Protein structure
Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| CMV pp65 | CMVPP65-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | CMV pp65 (25–305) AviHis |
| HLA-E*01:03 | HLAE0103-HP005 | Human | HEK293 | Human Peptide Ready HLA-E*01:03&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| HLA-A*31:01 | HLAA3101-HP001 | Human | HEK293 | Human Peptide Ready HLA-A*31:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.1 EU per μg by the LAL method. 100 μg | HLA-A*31:01 (25–305) AviHis |
| KRAS G12D | KRASG12D-HB001 | Human | HEK293 | Biotinylated Human KRAS G12D TCR&CD3 Complex Nanodisc Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D His |
| MAGE-A4 | MAGEA4-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| GP100 Intron | GP100INTRON-HB001 | Human | HEK293 | Biotinylated Human HLA-A*24:02&B2M&GP100 Intron 4 (VYFFLPDHL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | GP100 Intron (25–305) AviHis |
| KRAS G12D | KRASG12D-HP007 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| KRAS G12D | KRASG12D-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| HPV16 E7 | HPV16E7-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HPV16 E7 (25–305) AviHis |
| KRAS G12V | KRASG12V-HP009 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per ug by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| EGFR L858R | EGFRL858R-HB003 | Human | HEK293 | Biotinylated Human HLA-A*33:03&B2M&EGFR L858R (HVKITDFGR) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | EGFR L858R (25–305) AviHis |
| KRAS G12V | KRASG12V-HB003 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| KRAS G12A | KRASG12A-HP002 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12A (25–305) AviHis |
| KRAS WT | KRASWT-HP005 | Human | HEK293 | Human HLA-A*03:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS WT (25–305) AviHis |
| EBV LMP1 | EBVLMP1-HP001 | Human | HEK293 | Human HLA-E*01:03&B2M&EBV LMP1 (GGDPHLPTL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | EBV LMP1 (22–302) AviHis |
| HLA-E*01:03 | HLAE0103-HB002 | Human | HEK293 | Biotinylated Human HLA-E*01:03&B2M&Peptide (VMAPRTLVL) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| FcRn | FCRN-AB001 | Human | HEK293 | Anti-FcRn Antibody (Rozanolixizumab Biosimilar) Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | FcRn |
| HLA-B*57:01 | HLAB5701-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-B*57:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-B*57:01 (25–362) AviHis |
| MAGE-A1 | MAGEA1-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A1 (25–305) AviHis |
| MAGE-A2 | MAGEA2-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A2 (KMVELVHFL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A2 (25–305) AviHis |